https://www.avient.com/sites/default/files/2023-05/Mevopur Healthcare Colorants and Formulations Amber for Pharma Application Bulletin.pdf
Mevopur™ Healthcare Colorants and Formulations
Amber Colorants for Pharmaceutical Packaging
Avient constantly monitors the evolution of
regulations in the healthcare industry, and
develops compliant products well before those
regulations go into effect.
Mevopur Healthcare
Colorants and Formulations in amber tones
provide the safety of pre-tested raw materials
while protecting and prolonging the shelf life of
pharmaceuticals and nutraceuticals in amber PET
packaging products.
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified sites,
providing global consistency and increased
security of supply
• Documented change control beyond CAS
number level, reducing risk of change
• Non-phthalate and formulated without
animal-derived substances
• Different tones of amber available on request
—more or less red or yellow and/or lighter
or darker
• Also available in liquid form
REGULATORY SUPPORT
• Pre-tested raw materials:
- ISO 10993-1 and USP parts
(Class VI)
- European Pharmacopeia, monograph
3.1.15, USP and elemental analysis
as per ICH Q3D
- USP criteria appearance of solution,
color
• Registered Drug Master File (Type III) by
the FDA
• Food contact compliance established with
FDA/EU*
• YBB00102002-2015 (oral liquid pharmaceutical
PET bottles) compliance support
APPLICATION BULLETIN
* FDA/EU compliance
information available
upon request
Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Colorants and Formulations Special Effects Application Bulletin_0.pdf
Mevopur™ Healthcare Colorants and Formulations
Special Effect Colorants for Healthcare Devices and
Pharmaceutical Packaging
Self-administered medication, for example via
pen devices and inhalers, has been the norm for
many years.
Ingredients used in the
Mevopur™ portfolio have been tested to industry
standards that support applications in both
medical devices and pharmaceutical packaging.*
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified
manufacturing sites, providing global
consistency and increased security of supply
• Documented change control beyond CAS
number, reducing risk of change
• Non-phthalate and formulated without
animal-derived substances
• Available as pre-colored formulation or
concentrate and for use in different polymers
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III) and/or
Device Master File
• Food contact established with FDA/EU**
APPLICATION BULLETIN
* Design note: Effect colors require careful consideration of part design and
polymer flow paths to minimize visible flow lines.
https://www.avient.com/industries/consumer/home-household/disposables
We can give you design flexibility with both liquid and solid colorants to make your products pop.
https://www.avient.com/sites/default/files/2021-01/certificate-of-amendment-modification-avient-colorants-canada-inc.pdf
Certificate of Amendment
Loi canadienne sur les sociétés par actionsCanada Business Corporations Act
Certificat de modification
Avient Colorants Canada Inc.
942266-8
Corporate name / Dénomination sociale
Corporation number / Numéro de société
Raymond Edwards
Date of amendment (YYYY-MM-DD)
Date de modification (AAAA-MM-JJ)
Director / Directeur
2021-01-15
I HEREBY CERTIFY that the articles of the
above-named corporation are amended under
section 178 of the Canada Business
Corporations Act as set out in the attached
articles of amendment.
Corporation number
Numéro de la société
2
942266-8
The articles are amended as follows
Les statuts sont modifiés de la façon suivante
3
The corporation changes its name to:
La dénomination sociale est modifiée pour :
Avient Colorants Canada Inc.
https://www.avient.com/company/sustainability/sustainability-report/products/markets/healthcare-case-study
Mevopur™ Healthcare Bio-Based Polymer Solutions are color and performance-enhancing additive solutions formulated with bio-based polymers for healthcare applications.
Remafin™ EP White Colorants for Pharmaceutical Packaging designed for a range of pharmaceuticals, safeguarding light transmission while meeting regulatory requirements.
https://www.avient.com/investor-center/news/polyone-appoints-giuseppe-di-salvo-vice-president-investor-relations-justin-m-hess-vice-president-corporate-controller
in 2011 as assistant controller, a position he held until being named director of finance for the company's Color, Additives and Inks business segment.
He joined the company in 2010 and has since advanced through progressively increasing roles of global responsibility, including external reporting manager; assistant corporate controller; finance director for Color, Additives and Inks; and finance director for
https://www.avient.com/products/polymer-additives/barrier-and-scavenger-additives/colormatrix-amosorb-low-haze
Color and Additives Solutions Overview
Colorant and additives overview and capabilities
https://www.avient.com/idea/boosting-rpet-quality-and-safety-packaging
Avient has developed a "Heat Stability Protocol" to screen new additive solutions for their impact on color and NIAS through two full recycle loops at 100% recycled content.
This provides minimal effect on color shift and product safety.
https://www.avient.com/idea/changing-regulations-ivdr
Backed by robust bio-compatibility pre-testing, healthcare quality systems, and change control standards, these ‘medical grade’ concentrates and pre-color formulations can help minimize risk and avoid high costs of non-compliance.
Mevopur™ Custom Colors and Formulations
https://www.avient.com/industries/consumer/consumer-staples/everyday-essentials
With colors that are on-trend and inspiring.
Color Cosmetics